Natus Medical Incorporated announced its financial guidance for the first quarter and full year 2017. For the full year 2017, the company expects to report revenue of $505.0 million to $510.0 million and non-GAAP earnings per share of $1.80 to $1.85.

For the first quarter of 2017, the company expects to report revenue of $122.0 million to $124.0 million and non-GAAP earnings per share of $0.32 to $0.34.

The company expects to report revenue of approximately $107.5 million to $108.0 million for the fourth quarter of 2016, compared to prior guidance of $107.0 million to $109.0 million.

For the full year 2016, the company expects revenue of $381.5 million to $382.0 million compared to prior guidance of $381.2 million to $383.2 million. The company's earnings growth gone from $0.63 to this year, the company looks to close in the $1.63 to $1.66 range. The company's gross profit margins, how it has increased from 57% to through 3 quarters of this year to 62%. But the company anticipates ending up at around 63% gross profit margin this year 2016, especially when the company back the Venezuela business.